Search
for
Sort by
Research 691–720 of 1000+
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Treating Alopecia Areata: Current Practices Versus New Directions
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Alopecia Areata: An Update on Treatment Options for Children
- Treatment of Alopecia Areata with Simvastatin/Ezetimibe
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- Identification of differentially expressed miRNAs in alopecia areata that target immune-regulatory pathways
- Human hair follicle transcriptome profiling: a minimally invasive tool to assess molecular adaptations upon low‐volume, high‐intensity interval training
- Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata
- Alopecia areata
- Two Birds that Exclude Each Other: The Renbök Phenomenon
- Janus kinase inhibitors for the use of alopecia areata: A promising therapeutic of the future
- 570 Targeting JAK/STAT and Wnt/b-catenin pathways and 5a-reductase activity to develop an effective anti-hair loss product
- 865 Conditional ablation of JAK-STAT5 signaling induces anagen hair growth
- 700 Oncostatin M is upstream of JAK-STAT signaling during the murine hair cycle
- 706 Predictive modeling of patient response to JAK/STAT inhibitors and dynamic patient-matching
- In reply
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- JAK inhibitors for the treatment of alopecia areata
- Strategies for Managing Suboptimal Response to JAK Inhibitors in Alopecia Areata
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Oclacitinib Treatment and Surgical Management in a Case of Periocular Eosinophilic Furunculosis and Vasculitis with Secondary Eyelid Fusion in a Diabetic Cat
- Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis
- Tofacitinib in the Management of Alopecia Universalis
- Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study
- Advances in Vitiligo Treatment
- Targeted immunotherapy for hair regrowth and regeneration